Evidence map›Paper›PMID 36158494›Full record

ReviewWorld journal of clinical cases2022

Update on gut microbiota in gastrointestinal diseases.

Atsushi Nishida, Kyohei Nishino, Masashi Ohno, Keitaro Sakai, Yuji Owaki, Yoshika Noda, Hirotsugu Imaeda

Abstract readReview
In one paragraph

Review in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Gut microbiota therapy in gastrointestinal diseases.Frontiers in cell and developmental biology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Atsushi NishidaDepartment of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 526-8580, Japan. atsuda@belle.shiga-med.ac.jp.
Kyohei NishinoDepartment of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 526-8580, Japan.
Masashi OhnoDepartment of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 526-8580, Japan.
Keitaro SakaiDepartment of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 526-8580, Japan.
Yuji OwakiDepartment of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 526-8580, Japan.
Yoshika NodaDepartment of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 526-8580, Japan.
Hirotsugu ImaedaDepartment of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 526-8580, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human gut is a complex microbial ecosystem comprising approximately 100 trillion microbes collectively known as the "gut microbiota". At a rough estimate, the human gut microbiome contains almost 3.3 million genes, which are about 150 times more than the total human genes present in the human genome. The vast amount of genetic information produces various enzymes and physiologically active substances. Thus, the gut microbiota contributes to the maintenance of host health; however, when healthy microbial composition is perturbed, a condition termed "dysbiosis", the altered gut microbiota can trigger the development of various gastrointestinal diseases. The gut microbiota has consequently become an extremely important research area in gastroenterology. It is also expected that the results of research into the gut microbiota will be applied to the prevention and treatment of human gastrointestinal diseases. A randomized controlled trial conducted by a Dutch research group in 2013 showed the positive effect of fecal microbiota transplantation (FMT) on recurrent

Indexed as

Clostridioides difficile (Clostridium) infectionFecal microbiota transplantationInflammatory bowel diseaseIrritable bowel syndromeProbiotics

Identifiers

PMID36158494
PMCPMC9372855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.